首页> 外文期刊>Journal of Liquid Chromatography & Related Technologies >STABILITY-INDICATING HPLC METHOD FOR THE DETERMINATION OF THE STABILITY OF EXTEMPORANEOUSLY PREPARED NOREPINEPHRINE PARENTERAL SOLUTIONS
【24h】

STABILITY-INDICATING HPLC METHOD FOR THE DETERMINATION OF THE STABILITY OF EXTEMPORANEOUSLY PREPARED NOREPINEPHRINE PARENTERAL SOLUTIONS

机译:稳定性指示HPLC法测定临时制备的去甲肾上腺素肠胃外溶液的稳定性

获取原文
获取原文并翻译 | 示例
           

摘要

A stability-indicating HPLC method was developed for analysis of norepinephrine in the presence of the degradation products. The stability of extemporaneously compounded norepinephrine syringes was investigated using this method. The sterile preparations of norepinephrine were compounded to the strength of 8 µg/mL in accordance with USP (United States Pharmacopeia) 797 standards. To carry out the stability testing of these products, these syringes were stored under three different temperature conditions of −20°C, 2-6°C, 22-25°C, and light-protected at 22-25°C. Three injections from each temperature were withdrawn and were assessed for stability on days 0, 7, 15, 21, and 30 as per the USP guidelines. The assay of norepinephrine was examined by this calibrated stability-indicating HPLC method. No precipitation, cloudiness, or color change was observed during this study at all temperatures. The assay content by HPLC revealed that norepinephrine syringes retain greater than at least 90% of the initial concentrations for 30 d. Norepinephrine syringes in the final concentration of 8 µg/mL and diluted in normal saline are stable for at least 30 d under all the conditions studied. The stability analysis results show that the shelf-life observed was far better than their recommended expiration dates.View full textDownload full textKeywordscompounding, HPLC, intravenous, norepinephrine, stability, stability-indicatingRelated var addthis_config = { ui_cobrand: "Taylor & Francis Online", services_compact: "citeulike,netvibes,twitter,technorati,delicious,linkedin,facebook,stumbleupon,digg,google,more", pubid: "ra-4dff56cd6bb1830b" }; Add to shortlist Link Permalink http://dx.doi.org/10.1080/10826076.2011.636472
机译:开发了一种指示稳定性的HPLC方法,用于在降解产物存在下分析去甲肾上腺素。使用这种方法研究了临时复方去甲肾上腺素注射器的稳定性。根据USP(美国药典)<797>标准,去甲肾上腺素的无菌制剂的浓度为8 µg / mL。为了进行这些产品的稳定性测试,将这些注射器分别存储在20°C,2-6°C,22-25°C的三种不同温度条件下,并在22-25°C避光。从每个温度撤回3次注射,并根据USP指南在第0、7、15、21和30天评估稳定性。用该校准的指示稳定性的HPLC方法检查去甲肾上腺素的含量。在此研究中,在所有温度下均未观察到沉淀,混浊或颜色变化。 HPLC测定的内容显示,去甲肾上腺素注射器在30天内保留大于初始浓度的至少90%。在所有研究条件下,去甲肾上腺素注射器的终浓度为8 µg / mL,并在生理盐水中稀释,稳定至少30 d。稳定性分析结果表明,观察到的保质期比其建议的有效期要好得多。查看全文下载全文关键字化合物,HPLC,静脉内,去甲肾上腺素,稳定性,指示稳定性的相关变量var addthis_config = {ui_cobrand:“ Taylor&Francis Online”, services_compact:“ citeulike,netvibes,twitter,technorati,美味,linkedin,facebook,stumbleupon,digg,google,更多”,发布:“ ra-4dff56cd6bb1830b”};添加到候选列表链接永久链接http://dx.doi.org/10.1080/10826076.2011.636472

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号